Skip to main content
. 2021 Feb 9;11(2):e044054. doi: 10.1136/bmjopen-2020-044054

Table 5.

Cost-effectiveness results for a cohort of 1000 patients, where those undergoing PCI have stopped all anti-anginal medical therapy

Treatment Total costs Total QALYs Cost difference QALY difference ICER
Placebo £410 405 796.092
PCI £1 913 852 813.661 £1 503 447 17.569 £85 576*

*ICER calculated prior to rounding.

ICER, incremental cost-effectiveness ratio; PCI, percutaneous coronary intervention; QALYs, quality-adjusted life-years.